0001678359-16-000001.txt : 20160628 0001678359-16-000001.hdr.sgml : 20160628 20160628120439 ACCESSION NUMBER: 0001678359-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160628 DATE AS OF CHANGE: 20160628 EFFECTIVENESS DATE: 20160628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IFM Therapeutics, Inc. CENTRAL INDEX KEY: 0001678359 IRS NUMBER: 474954875 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-265896 FILM NUMBER: 161735334 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2794 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0707 D LIVE 0001678359 IFM Therapeutics, Inc. 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 857-201-2794 DELAWARE None None Corporation true 2015 Gary Glick 400 Technology Square 10th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Mr. Glick is a director and the President of the Issuer. Jean-Francois Formela 400 Technology Square 10th Floor Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2016-06-17 false true false 0 Indefinite 17141595 Indefinite false 4 0 0 0 false IFM Therapeutics, Inc. Marianne McKeon Marianne McKeon Counsel 2016-06-28